Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi

Bahl, D., Bogner, R.H., 2006. Amorphization of indomethacin by co-grinding with Neusilin US2:
Amorphization kinetics, physical stability and mechanism. Pharm. Res. 23, 2317-2325.
Bansal, A., Li, X., Lauermann, I., Lewis, N.S., Yi, S.I., Weinberg, W.H., 1996. Alkylation of Si
surfaces using a two-step halogenation/Grignard route. J. Am. Chem. Soc. 118, 7225-7226.
Bashiri-Shahroodi, A., Nassab, P.R., Szabó-Révész, P., Rajkó, R., 2008. Preparation of a solid
dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev. Ind.
Pharm. 34, 781-788.
Batra, I., Coffer, J.L., Canham, L.T., 2006. Electronically-responsive delivery from a calcified
mesoporous silicon structure. Biomed. Microdevices 8, 93-97.
Beck, J.S., Vartuli, J.C., Roth, W.J., Leonowicz, M.E., Kresge, C.T., Schmitt, K.D., Chu, C.T.W.,
Olson, D.H., Sheppard, E.W., McCullen, S.B., Higgins, J.B., Schlenker, J.L., 1992. A new family
of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 114,
10834–10843.
Betageri, G.V., Makarla, K.R., 1995. Enhancement of dissolution of glyburide by solid dispersion
and lyophilization techniques. Int. J. Pharm. 126, 155-160.
Beten, D.B., Amighi, K., Moës, A.J., 1995. Preparation of controlled-release coevaporates of
dipyridamole by loading neutral pellets in a fluidized-bed coating system. Pharm. Res. 12, 1269-
1272.
Bimbo, L.M., Sarparanta, M., Santos, H.A., Airaksinen, A.J., Mäkilä, E., Laaksonen, T., Peltonen,
L., Lehto, V.-P., Hirvonen, J., Salonen, J., 2010. Biocompatibility of thermally hydrocarbonized
porous silicon nanoparticles and their biodistribution in rats. ACS Nano 4, 3023-3032.
Bimbo, L.M., Mäkilä, E., Laaksonen, T., Lehto, V.-P., Salonen, J., Hirvonen, J., Santos, H.A.,
2011. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles.
Biomaterials 32, 2625-2633.
Blagden, N., de Matas, M., Gavan, P.T., York, P., 2007. Crystal engineering of active
pharmaceutical ingredients to improve solubility and dissolution rates. Adv. Drug Delivery Rev.
59, 617-630.
Blumen, S.R., Cheng, K., Ramos-Nino, M.E., Taatjes, D.J., Weiss, D.J., Landry, C.C., Mossman,
B.T., 2007. Unique uptake of acid-prepared mesoporous spheres by lung epithelial and
mesothelioma cells. Am. J. Respir. Cell Mol. Biol. 36, 333-342.
Boissière, C., Larbot, A., van der Lee, A., Kooyman, P.J., Prouzet, E., 2000. A new synthesis of
mesoporous MSU-X silica controlled by a two-step pathway. Chem. Mater. 12, 2902-2913.
Borm, P.J.A., Schins, R.P.F., Albrecht, C., 2004. Inhaled particles and lung cancer, part B:
Paradigms and risk assessment. Int. J. Cancer 110, 3-14.
Boukherroub, R., Petit, A., Loupy, A., Chazalviel, J.-N., Ozanam, F., 2003. Microwave-assisted
chemical functionalization of hydrogen-terminated porous silicon surfaces. J. Phys. Chem. B 107,
13459-13462.
Bowditch, A.P., Waters, K., Gale, H., Rice, P., Scott, E.A.M., Canham, L.T., Reeves, C.L., Loni,
A., Cox, T.I., 1999. In-vivo assessment of tissue compatibility and calcification of bulk and porous
46